iSUN3D
A comprehensive digital orthotic solution provider specializing in 3D-printed custom insoles and footwear through an integrated 'scanning-design-printing' ecosystem.
- CEO / Founder
- Kevin Yang
- Team Size
- 50-200
- Stage
- Scaling / Growth stage (Recently launched a centralized flexible manufacturing center in Wuhan aiming for 1,000+ printers by 2026).
- Total Funding
- $35.5M
- Latest Round
- Post-IPO Equity
- Key Investors
- ["Shenzhen Capital Group (SCGC)","HTI Group","Guangdong Hongtu Technology"]
Technology & Products
Key Products
["FlexOne Series High-Speed Resin Printers","iSUN3D Custom Insole Design Software (Cloud-based)","3D Foot Scanners (iSUN-L5 and portable series)","FLX Series FDM Insole Printers","Specialized 3D Printing Materials (TPU filaments and flexible resins)","Centralized Flexible Manufacturing Service"]
Technological Advantage
Proprietary single-component elastomers capable of 20 MPa tensile strength and over 1,000,000 flex cycles, combined with a vertically integrated supply chain inherited from parent company eSUN.
Market & Competition
Target Customers
Orthopedic clinics, rehabilitation centers, hospitals, professional athletes, and global footwear brands.
Industry Verticals
["Medical & Healthcare (Orthopedics)","Rehabilitation Medicine","Footwear & Apparel","Sports Science","Additive Manufacturing"]
Competitors
["Materialise (Phits)","Aetrex","Voxelcare","FitMyFoot"]